Table of Contents Asia-Pacific Heparin (Low Molecular Weight) Market Report 2017 1 Heparin (Low Molecular Weight) Overview 1.1 Product Overview and Scope of Heparin (Low Molecular Weight) 1.2 Classification of Heparin (Low Molecular Weight) by Product Category 1.2.1 Asia-Pacific Heparin (Low Molecular Weight) Market Size (Sales) Comparison by Types (2012-2022) 1.2.2 Asia-Pacific Heparin (Low Molecular Weight) Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Enoxaparin 1.2.4 Dalteparin 1.2.5 Tinzaparin 1.2.6 Fraxiparine 1.3 Asia-Pacific Heparin (Low Molecular Weight) Market by Application/End Users 1.3.1 Asia-Pacific Heparin (Low Molecular Weight) Sales (Volume) and Market Share Comparison by Applications (2012-2022) 1.3.2 Treatment of Venous Thromboembolism 1.3.3 Complications of Pregnancy 1.3.4 Cardioversion of Atrial Fibrillation/Flutter 1.3.5 Others 1.4 Asia-Pacific Heparin (Low Molecular Weight) Market by Region 1.4.1 Asia-Pacific Heparin (Low Molecular Weight) Market Size (Value) Comparison by Region (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Japan Status and Prospect (2012-2022) 1.4.4 South Korea Status and Prospect (2012-2022) 1.4.5 Taiwan Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.4.7 Southeast Asia Status and Prospect (2012-2022) 1.4.8 Australia Status and Prospect (2012-2022) 1.5 Asia-Pacific Market Size (Value and Volume) of Heparin (Low Molecular Weight) (2012-2022) 1.5.1 Asia-Pacific Heparin (Low Molecular Weight) Sales and Growth Rate (2012-2022) 1.5.2 Asia-Pacific Heparin (Low Molecular Weight) Revenue and Growth Rate (2012-2022) 2 Asia-Pacific Heparin (Low Molecular Weight) Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Heparin (Low Molecular Weight) Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Heparin (Low Molecular Weight) Sales Volume and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Asia-Pacific Heparin (Low Molecular Weight) Revenue and Share by Players/Suppliers (2012-2017) 2.2 Asia-Pacific Heparin (Low Molecular Weight) (Volume and Value) by Type 2.2.1 Asia-Pacific Heparin (Low Molecular Weight) Sales and Market Share by Type (2012-2017) 2.2.2 Asia-Pacific Heparin (Low Molecular Weight) Revenue and Market Share by Type (2012-2017) 2.3 Asia-Pacific Heparin (Low Molecular Weight) (Volume) by Application 2.4 Asia-Pacific Heparin (Low Molecular Weight) (Volume and Value) by Region 2.4.1 Asia-Pacific Heparin (Low Molecular Weight) Sales and Market Share by Region (2012-2017) 2.4.2 Asia-Pacific Heparin (Low Molecular Weight) Revenue and Market Share by Region (2012-2017) 3 China Heparin (Low Molecular Weight) (Volume, Value and Sales Price) 3

List of Tables and Figures Figure Product Picture of Heparin (Low Molecular Weight) Figure Asia-Pacific Heparin (Low Molecular Weight) Sales Volume (K Units) by Type (2012-2022) Figure Asia-Pacific Heparin (Low Molecular Weight) Sales Volume Market Share by Type (Product Category) in 2016 Figure Enoxaparin Product Picture Figure Dalteparin Product Picture Figure Tinzaparin Product Picture Figure Fraxiparine Product Picture Figure Asia-Pacific Heparin (Low Molecular Weight) Sales (K Units) by Application (2012-2022) Figure Asia-Pacific Sales Market Share of Heparin (Low Molecular Weight) by Application in 2016 Figure Treatment of Venous Thromboembolism Examples Table Key Downstream Customer in Treatment of Venous Thromboembolism Figure Complications of Pregnancy Examples Table Key Downstream Customer in Complications of Pregnancy Figure Cardioversion of Atrial Fibrillation/Flutter Examples Table Key Downstream Customer in Cardioversion of Atrial Fibrillation/Flutter Figure Others Examples Table Key Downstream Customer in Others Figure Asia-Pacific Heparin (Low Molecular Weight) Market Size (Million USD) by Region (2012-2022) Figure China Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure Japan Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure South Korea Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure Taiwan Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure India Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure Southeast Asia Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure Australia Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Heparin (Low Molecular Weight) Sales Volume (K Units) and Growth Rate (2012-2022) Figure Asia-Pacific Heparin (Low Molecular Weight) Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Heparin (Low Molecular Weight) Market Major Players Product Sales Volume (K Units)(2012-2017) Table Asia-Pacific Heparin (Low Molecular Weight) Sales (K Units) of Key Players/Suppliers (2012-2017) Table Asia-Pacific Heparin (Low Molecular Weight) Sales Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Heparin (Low Molecular Weight) Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Heparin (Low Molecular Weight) Sales Share by Players/Suppliers Figure Asia-Pacific Heparin (Low Molecular Weight) Market Major Players Product Revenue (Million USD) 2012-2017 Table Asia-Pacific Heparin (Low Molecular Weight) Revenue (Million USD) by Players/Suppliers (2012-2017) Table Asia-Pacific Heparin (Low Molecular Weight) Revenue Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Hep